Frey, N. V., Gill, S., Hexner, E. O., Schuster, S., Nasta, S., Loren, A., . . . Porter, D. L. (2020). Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia. J Clin Oncol.
Chicago Style aipamenaFrey, Noelle V., et al. "Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia." J Clin Oncol 2020.
MLA aipamenaFrey, Noelle V., et al. "Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia." J Clin Oncol 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.